While many medical marijuana stocks are trading at jaw-dropping valuations, Insys may be a relative value given the potential approval of its synthetic THC drug, dronabinol.
While many medical marijuana stocks are trading at jaw-dropping valuations, Insys may be a relative value given the potential approval of its synthetic THC drug, dronabinol.